Action Ceapro - CZO

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,225

Prix Achat

0,16

Prix Vente

0,30

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Cap du marché

17,616M

Clôture Veille

0,225

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

78 293 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-3,65

Bénéfice par action (BPA)

-0,06

Chiffre d'affairess

9,63M

Bénéfice net

-4,71M

Secteur

Medicinal Chems,botanicl Pds

Industrie

Medicinal Chems,botanicl Pds

Siège social

Edmonton, Alberta, Can

Fondé

Ceapro Inc est coté dans le secteur Medicinal Chems,botanicl Pds de la TSX Venture Exchange avec le ticker CZO. Le dernier cours de clôture d'Ceapro était de $0,23. Au cours de la dernière année, les actions de Ceapro ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Ceapro compte actuellement 78 293 000 actions en circulation. La capitalisation boursière d'Ceapro est de $17,62 million. Ceapro a un ratio cours/bénéfice (ratio PE) de -3.65.

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:...

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS...

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

– Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical...

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

– 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D...

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS...

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:...

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS...

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

ISS states in its Aeterna Zentaris FOR recommendation that “on balance, the deal has strong strategic merit...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CZO - Frequently Asked Questions (FAQ)

What is the current Ceapro share price?

The current share price of Ceapro is $ 0,225

How many Ceapro shares are in issue?

Ceapro has 78 293 000 shares in issue

What is the market cap of Ceapro?

The market capitalisation of Ceapro is CAD 17,62M

What is the 1 year trading range for Ceapro share price?

Ceapro has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Ceapro?

The price to earnings ratio of Ceapro is -3,65

What is the cash to sales ratio of Ceapro?

The cash to sales ratio of Ceapro is 1,79

What is the reporting currency for Ceapro?

Ceapro reports financial results in CAD

What is the latest annual turnover for Ceapro?

The latest annual turnover of Ceapro is CAD 9,63M

What is the latest annual profit for Ceapro?

The latest annual profit of Ceapro is CAD -4,71M

What is the registered address of Ceapro?

The registered address for Ceapro is 7824 - 51 AVENUE NW, EDMONTON, ALBERTA, T6E 6W2

Which industry sector does Ceapro operate in?

Ceapro operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ZZE.HZidane Capital Corp	$ 0,055 (1 000,00%)	500k
ADEAdex Mining Inc	$ 0,01 (100,00%)	319k
TVITVI Pacific Inc	$ 0,01 (100,00%)	1 000
CLMConsolidated Lithium Metals Inc	$ 0,01 (100,00%)	610,85k
AQSAequus Pharmaceuticals Inc	$ 0,01 (100,00%)	282,7k
OVL.HOlivier Ventures Inc	$ 0,005 (-66,67%)	38,89k
WT.HWangton Capital Corp	$ 0,03 (-53,85%)	40k
CONECanada One Mining Corp	$ 0,015 (-50,00%)	174,67k
CANSWildpack Beverage Inc	$ 0,005 (-50,00%)	175,95k
SAI.HSunshine Agri Tech Inc	$ 0,005 (-50,00%)	35k
VPTVentripoint Diagnostics Ltd	$ 0,15 (76,47%)	3,99M
GOTGoliath Resources Limited	$ 1,55 (-29,55%)	3,04M
GPUSAlset AI Ventures Inc	$ 0,08 (-5,88%)	2,05M
PXPelangio Exploration Inc	$ 0,06 (50,00%)	1,88M
AAGAftermath Silver Ltd	$ 0,455 (-10,78%)	1,83M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ceapro Inc (CZO)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Ceapro Inc

CZO Dernières nouvelles

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris and Ceapro Complete Merger Transaction

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris and Ceapro Complete Merger Transaction

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

CZO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ceapro Inc (CZO) Cours

Ceapro Inc (CZO)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Ceapro Inc

CZO Dernières nouvelles

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris and Ceapro Complete Merger Transaction

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris and Ceapro Complete Merger Transaction

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

CZO - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS